Subscribe to Updates
Subscribe to our newsletter for the latest leadership tips, exclusive interviews, and expert advice from top CEOs. Simply enter your email below and stay ahead of the curve!.
Author: Daniel snow
[ad_1] In a Monday interview with CNBC’s Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the new pill format of the pharmaceutical giant’s weight loss drug will allow more people to use the medicine which had previously been available only as an injectable. “We are seeing, actually, that the pill is able to expand the market for a large group of people that have been waiting,” Doustdar said. “Predominantly, I would say the major barrier has been the taboo.”Many people have a needle phobia, Doustdar said, and he suggested that injectables have societal taboo. He also said injectable GLP-1s come…
[ad_1] BofA bullish on euro in 2026 due to US rates, China stimulus [ad_2] Source link
[ad_1] Bank of America recommends closing USD/JPY longs as pair approaches 160 [ad_2] Source link
[ad_1] Dollar slumps as political pressure on Powell ramps up [ad_2] Source link
[ad_1] Asia FX subdued, dollar slips on US probe into Fed’s Powell [ad_2] Source link
[ad_1] Dollar creeps higher; payrolls, tariffs ruling to set tone [ad_2] Source link
[ad_1] BofA expects further EUR/GBP downside in 2026 as UK-EU relations improve [ad_2] Source link
[ad_1] Asia FX flat as dollar rises before payrolls test; yuan firm after strong CPI [ad_2] Source link
[ad_1] BofA shifts to neutral on USD/CAD as loonie hits fair value [ad_2] Source link
[ad_1] History suggests large USD selloffs tend to occur in consecutive years: BofA [ad_2] Source link